CH₃CH₃
AI image · google/nano-banana-2-lite

Nootropics

A subject defined by intention rather than by mechanism: these are the substances people take to think better, and its four families — racetams, cholinergics, peptides and adaptogens — share no receptor, no scaffold and no legal status with one another. Evidence quality is the axis that actually matters here, and it runs the whole range: a prescription cholinesterase inhibitor with clinical trials behind it sits two clicks from a plant extract whose case for working is traditional use and self-report.

Being sold as a supplement is what makes this subject risky rather than dull. Powders bought by the gram are not assayed, "natural" is not a pharmacological category, and combinations get taken casually here in a way they would not with something that felt like a drug. The stimulant nootropics are not in this subject — caffeine, nicotine and modafinil are filed under Stimulants, by what they do.

AI image
General Open discussion — anything that fits nowhere narrower. no posts yet
photo: Anders Sandberg from Oxford, UK · CC BY
Racetams The piracetam family. 11 molecules 2 posts
photo: Cheng-Tao Lin · CC BY
Cholinergics Choline sources and acetylcholinesterase inhibitors. 5 molecules
AI image
Harm Reduction The practical safety page: testing, amounts, combinations, and when to get help. no posts yet
AI image
Legal Scheduling status, pending actions, and where the law actually stands. no posts yet
photo: DMTrott · CC BY-SA
Peptides Noopept, Semax, Selank. 4 molecules 2 posts
AI image
Receptors Binding profiles and mechanism of action. no posts yet
Adamantanes Memantine and bromantane: one cage, two unrelated drugs. 3 molecules 5 posts
photo: Krzysztof Ziarnek, Kenraiz · CC BY-SA
Adaptogens Herbal stress-response modulators. 5 molecules
AI image
Nature Natural occurrence — organisms, alkaloid content, endogenous chemistry. no posts yet
AI image
Chemistry Structure, synthesis, and analytical chemistry. no posts yet
Irams Unifiram and the piracetam-derived Florence series. Potent in rodents, untested in people. 2 molecules 3 posts
AI image
Addiction Help Dependence, withdrawal, and where to find real help. no posts yet
NMDA Glycine-site Agents Compounds that act on the NMDA receptor through its glycine co-agonist site, or raise glycine: HA-966, rapastinel, neboglamine, sarcosine. 4 molecules 2 posts Ampakines Positive modulators of the AMPA glutamate receptor, such as IDRA-21 and TAK-653. 2 molecules 2 posts Research Compounds Single compounds from drug-development programmes sold as nootropics, with no family of their own: PRL-8-53, J147, sipagladenant. 3 molecules 3 posts

No posts here yet.

Tell us something